# Pomegranate Skin Aging Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/pomegranate-skin-aging-randomized-trial-evidence-review
Category: evidence-review
Summary: Pomegranate Skin Aging Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-07-07
Reviewed by: Migaku Evidence Review
# Pomegranate Skin Aging Randomized Trial: What the Evidence Says

## Quick Answer

Pomegranate Skin Aging Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Dermocosmetic Potential of Punica granatum : A Systematic Review of Bioactive Compounds and Skincare Applications | systematic review | 1 | 2026-03-06 | 10.3390/antiox15030332 |
| Phytochemical Diversity of Punica granatum L. and Its Multi-Target Biological Functions | narrative review | 3 | 2026-04-21 | 10.3390/nu18081306 |

## What The Sources Report

- The methodology was designed to ensure a transparent and complete reporting of the evidence synthesis regarding the dermocosmetic properties of pomegranate extracts. [Pons-Rocamora Nerea (2026); evidence level 1]
- Next, we further refined this selection by excluding articles that lacked sufficient evidence to support contrasting arguments. [Pons-Rocamora Nerea (2026); evidence level 1]
- Archaeobotanical evidence indicates that the pomegranate was domesticated at a very early stage, dating back to the Neolithic period. [Kobylińska Zofia (2026); evidence level 3]
- To address these gaps, this review consolidates evidence into a translational chain that links product/matrix characteristics to phytochemical profiles, bioaccessibility and metabolism, and downstream multi-target biological outcomes. [Kobylińska Zofia (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For pomegranate skin aging randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Pons-Rocamora Nerea (2026). Dermocosmetic Potential of Punica granatum : A Systematic Review of Bioactive Compounds and Skincare Applications. DOI: 10.3390/antiox15030332. PMCID: PMC13024184. PMID: 41897478. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13024184/
- Kobylińska Zofia (2026). Phytochemical Diversity of Punica granatum L. and Its Multi-Target Biological Functions. DOI: 10.3390/nu18081306. PMCID: PMC13118560. PMID: 42075117. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13118560/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.